Download PDF
Synlett 2003(15): 2345-2348  
DOI: 10.1055/s-2003-43341
LETTER
© Georg Thieme Verlag Stuttgart · New York

A Model Route Toward the Synthesis of Conformationally Constrained Polyhydroxylated Dipeptides from Natural Carbohydrates

Alessandro Dondoni*a,b, Alberto Marra*a,b, Barbara Richichib
a Dipartimento di Chimica, Laboratorio di Chimica Organica, Università di Ferrara, Via Borsari 46, 44100 Ferrara, Italy
b Interdisciplinary Center for the Study of Inflammation, Università di Ferrara, Via Borsari 46, 44100 Ferrara, Italy
Fax: +39(0532)291167; e-Mail: adn@dns.unife.it;
Further Information

Publication History

Received 6 October 2003
Publication Date:
21 November 2003 (online)

    Permissions and Reprints All articles of this category

Abstract

Enantiopure 6,7-diacetoxy-3-t-butoxycarbonylamino-azabicyclo[3.3.0]octan-2-one-8-carboxylic acid 14 (pyrrolizidi­none amino acid) was synthesized in 14 steps and 5.8% overall yield from tri-O-benzyl-d-arabinose 5 through the formyl C-iminosugar 9 as a key intermediate.

Key words

integrins - peptidomimetics - pyrrolizidinone amino ­acids - reverse-turn - RGD

    References

  • 1a Olson GL. Bolin DR. Bonner MP. Bös M. Cook CM. Fry DC. Graves BJ. Hatada M. Hill DE. Kahn M. Madison VS. Rusiecki VK. Sarabu R. Sepinwall J. Vincent GP. Voss ME. J. Med. Chem.  1993,  36:  3039 
    CrossrefGoogle Scholar
  • 1b Gante J. Angew. Chem., Int. Ed. Engl.  1994,  33:  1699 
    CrossrefGoogle Scholar
  • 2a Peptide Secondary Structure Mimetics In Tetrahedron Symposia-in-Print   Vol. 49:  Kahn M. Elsevier; Amsterdam: 1993.  p.3433-3689  
    CrossrefGoogle Scholar
  • 2b Hanessian S. McNaughton-Smith G. Lombart H.-G. Lubell WD. Tetrahedron  1997,  53:  12789 ; and references cited therein
    CrossrefGoogle Scholar
  • 3a Halab L. Gosselin F. Lubell WD. Biopolymers  2000,  55:  101 
    CrossrefGoogle Scholar
  • 3b Dietrich E. Lubell WD. J. Org. Chem.  2003,  68:  6988 
    CrossrefGoogle Scholar
  • 4a Gillespie P. Cicariello J. Olson GL. Biopolymers  1997,  43:  191 
    CrossrefGoogle Scholar
  • 4b Takeuchi Y. Marshall GR. J. Am. Chem. Soc.  1998,  120:  5363 
    CrossrefGoogle Scholar
  • 4c Belvisi L. Bernardi A. Manzoni L. Potenza D. Scolastico C. Eur. J. Org. Chem.  2000,  2563 
    CrossrefGoogle Scholar
  • 5a Lombart H.-G. Lubell WD. J. Org. Chem.  1994,  59:  6147 
    CrossrefGoogle Scholar
  • 5b Lombart H.-G. Lubell WD. J. Org. Chem.  1996,  61:  9437 
    CrossrefGoogle Scholar
  • 6a Polyak F. Lubell WD. J. Org. Chem.  2001,  66:  1171 
    CrossrefGoogle Scholar
  • 6b Feng Z. Lubell WD. J. Org. Chem.  2001,  66:  1181 
    CrossrefGoogle Scholar
  • 6c Artale E. Banfi G. Belvisi L. Colombo L. Colombo M. Manzoni L. Scolastico C. Tetrahedron  2003,  59:  6241 
    CrossrefGoogle Scholar
  • 7a Hruby VJ. Li G. Haskell-Luevano C. Shenderovich M. Biopolymers  1997,  43:  219 
    CrossrefPubMedGoogle Scholar
  • 7b Wang W. Yang J. Ying J. Xiong C. Zhang J. Cai C. Hruby VJ. J. Org. Chem.  2002,  67:  6353 
    CrossrefPubMedGoogle Scholar
  • 8a Gosselin F. Lubell WD. J. Org. Chem.  1998,  63:  7463 
    CrossrefPubMedGoogle Scholar
  • 8b Angiolini M. Araneo S. Belvisi L. Cesarotti E. Checchia A. Crippa L. Manzoni L. Scolastico C. Eur. J. Org. Chem.  2000,  2571 
    CrossrefPubMedGoogle Scholar
  • 8c Gosselin F. Lubell WD. J. Org. Chem.  2000,  65:  2163 
    CrossrefPubMedGoogle Scholar
  • 9a Haubner R. Schmitt W. Hölzemann G. Goodman SL. Jonczyk A. Kessler H. J. Am. Chem. Soc.  1996,  118:  7881 
    CrossrefGoogle Scholar
  • 9b Belvisi L. Bernardi A. Checchia A. Manzoni L. Potenza D. Scolastico C. Castorina M. Cupelli A. Giannini G. Carminati P. Pisano C. Org. Lett.  2001,  3:  1001 
    CrossrefGoogle Scholar
  • 9c Marinelli L. Lavecchia A. Gottschalk K.-E. Novellino E. Kessler H. J. Med. Chem.  2003,  46:  4393 
    CrossrefGoogle Scholar
  • 10a Haubner R. Finsinger D. Kessler H. Angew. Chem. Int. Ed.  1997,  36:  1374 
    CrossrefGoogle Scholar
  • 10b Gottschalk K.-E. Kessler H. Angew. Chem. Int. Ed.  2002,  41:  3767 
    CrossrefGoogle Scholar
  • 10c Hynes RO. Nature Med.  2002,  8:  918 
    CrossrefGoogle Scholar
  • 11 Another class of conformationally constrained polyhydroxylated dipeptides has been recently described, see: Tremmel P. Brand J. Knapp V. Geyer A. Eur. J. Org. Chem.  2003,  878 
    CrossrefGoogle Scholar
  • 12 Arap W. Pasqualini R. Ruoslahti E. Science  1998,  279:  377 
    CrossrefGoogle Scholar
  • Compound 6 was prepared in gram scale quantities by stereoselective addition of 2-lithiothiazole to the nitrone derived from d-arabinose 5 followed by dehydroxylation of the resulting open-chain hydroxylamine and cyclization by intramolecular nitrogen-carbon bond formation via SN2 process. See:
  • 13a Dondoni A. Perrone D. Tetrahedron Lett.  1999,  40:  9375 
    Google Scholar
  • 13b Dondoni A. Giovannini P. Perrone D. J. Org. Chem.  2002,  62:  7203 
    Google Scholar
  • 15 Dondoni A. Marra A. Scherrmann M.-C. Bertolasi V. Chem.-Eur. J.  2001,  7:  1371 
    Google Scholar
  • 16 Schmidt U. Lieberknecht A. Wild J. Synthesis  1984,  53 
    Article in Thieme ConnectGoogle Scholar
  • 18 Unnatural hetero-bifunctional ligands bearing the sialyl Lewis oligosaccharide and the RGD peptide sequence have been recently prepared, see: Matsuda M. Nishimura S.-I. Nakajima F. Nishimura T. J. Med. Chem.  2001,  44:  715 
    CrossrefGoogle Scholar
  • The LDT-mediated binding between the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its receptor, the α4β7 integrins, is responsible for the lymphocytes recruitment to inflamed colon. Cyclic peptidomimetics containing the LDT motif are inhibitors of this recognition process and therefore may lead to a new, organ specific treatment of inflammatory diseases.
  • 19a Gottschling D. Boer J. Schuster A. Holzmann B. Kessler H. Angew. Chem. Int. Ed.  2002,  41:  3007 
    CrossrefGoogle Scholar
  • 19b Gottschling D. Boer J. Marinelli L. Voll G. Haupt M. Schuster A. Holzmann B. Kessler H. ChemBioChem  2002,  575 
    CrossrefGoogle Scholar
14

Compound 7. [α]D = +22.2 (c 1.2, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 7.74 (d, J = 3.3 Hz, 1 H, Th), 7.32-7.14 (m, 16 H, 3 × Ph, Th), 4.68, 4.50 (2 × d, 2 H, J = 11.7 Hz, PhCH 2O), 4.58, 4.46 (2 × d, J = 11.7 Hz, 2 H, PhCH 2O), 4.44 (d, J 2,3 = 4.8 Hz, 1 H, H-2), 4.27 (dd, J 3,4 = 4.5 Hz, 1 H, H-3), 4.16 (dd, J 4,5 = 6.6 Hz, 1 H, H-4), 4.01, 3.82 (2 × d, J = 13.7 Hz, 2 H, PhCH 2N), 3.63 (dd, J 5,6 = 4.5 Hz, J 6,OH = 6.3 Hz, 2 H, 2 × H-6), 3.34 (dt, 1 H, H-5), 2.65 (t, 1 H, OH). Compound 8. [α]D = +35.5 (c 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 3.3 Hz, 1 H, Th), 7.38-7.17, 7.00-6.96 (2 × m, 16 H, 3 × Ph, Th), 6.81-6.72 (m, 4 H, MeOPh), 4.69, 4.54 (2 × d, J = 11.8 Hz, 2 H, PhCH 2O), 4.46 (d, J 2,3 = 2.5 Hz, 1 H, H-2), 4.37, 4.31 (2 × d, J = 11.9 Hz, 2 H, PhCH 2O), 4.29 (dd, J 3,4 = 2.3 Hz, 1 H, H-3), 4.17 (dd, J 5,6a = 7.1 Hz, J 6a,6b = 9.0 Hz, 1 H, H-6a), 4.12 (dd, J 4,5 = 5.6 Hz, 1 H, H-4), 4.08, 3.99 (2 × d, J = 13.6 Hz, 2 H, PhCH 2N), 3.92 (dd, J 5,6b = 5.1 Hz, 1 H, H-6b), 3.77 (s, 3 H, Me), 3.67 (ddd, 1 H, H-5). Compound 9. [α]D = +2.5 (c 0.6, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 9.30 (d, J = 1.3 Hz, 1 H, CHO), 7.40-7.20, 7.16-7.11 (2 × m, 15 H, 3 × Ph), 6.84 (s, 4 H, MeOPh), 4.59, 4.51 (2 × d, J = 11.8 Hz, 2 H, PhCH 2O), 4.44, 4.28 (2 × d, J = 11.7 Hz, 2 H, PhCH 2O), 4.29 (dd, J 5,6a = 7.7 Hz, J 6a,6b = 9.3 Hz, 1 H, H-6a), 4.27, 3.76 (2 × d, J = 13.2 Hz, 2 H, PhCH 2N), 4.11 (dd, J 2,3 = 1.2 Hz, J 3,4 = 1.5 Hz, 1 H, H-3), 4.10 (dd, J 4,5 = 4.3 Hz, 1 H, H-4), 4.09 (dd, J 5,6b = 5.3 Hz, 1 H, H-6b), 3.78 (s, 3 H, Me), 3.68 (ddd, 1 H, H-5), 3.38 (dd, 1 H, H-2). 13C NMR (100 MHz, CDCl3): δ = 204.7 (C-1), 153.9, 153.0, 115.4, 114.6 (MeOPh), 138.8, 137.5, 137.4, 129.1-127.5 (3 × Ph), 84.2 (C-3), 80.0 (C-4), 76.2 (C-2), 71.8 (PhCH2O), 71.4 (PhCH2O), 67.2 (C-6), 66.2 (C-5), 60.7 (PhCH2N), 55.8 (MeO).

17

Compound 11. [α]D = -8.7 (c 0.8, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.34-7.18 (m, 20 H, 4 × Ph), 7.08 (br s, 1 H, NH), 6.81-6.72 (m, 4 H, MeOPh), 6.21 (d, J = 8.2 Hz, 1 H, CH=), 5.09, 5.01 (2 × d, J = 12.3 Hz, 2 H, PhCH 2OCO), 4.51, 4.46 (2 × d, J = 11.8 Hz, 2 H, PhCH 2O), 4.45 (s, 2 H, PhCH 2O), 4.12 (dd, J 5,6a = 7.2 Hz, J 6a,6b = 9.4 Hz, 1 H, H-6a), 4.04 (dd, J 3,4 = 3.0 Hz, J 4,5 = 5.8 Hz, 1 H, H-4), 3.92 (dd,
J 5,6b = 4.7 Hz, 1 H, H-6b), 3.89, 3.80 (2 × d, J = 13.6 Hz,
2 H, PhCH 2N), 3.89 (dd, J 2,3 = 4.8 Hz, 1 H, H-3), 3.78, 3.71 (2 × s, 6 H, 2 × Me), 3.56 (dd, 1 H, H-2), 3.44 (ddd, 1 H, H-5). Compound 13. [α]D = -45.3 (c 0.4, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 6.86-6.79 (m, 4 H, MeOPh), 5.50 (dd, J 6,7 = J 7,8 = 7.7 Hz, 1 H, H-7), 5.19 (dd, J 5,6 = 7.3 Hz, 1 H, H-6), 4.94 (br d, J 3,NH = 5.5 Hz, 1 H, NH), 4.75 (dd, J 8,9a = 3.9, J 9a,9b = 10.0 Hz, 1 H, H-9a), 4.44 (dd, J 3,4a = 6.9 Hz, J 3,4b = 12.1 Hz, 1 H, H-3), 4.28 (ddd, J 8,9b = 1.0 Hz, 1 H, H-8), 3.87 (dd, 1 H, H-9b), 3.76 (s, 3 H, Me), 3.64 (dd, J 4a,5 = 5.3 Hz, J 4b,5 = 10.1 Hz, 1 H,, H-5), 2.96 (ddd, J 4a,4b = 11.8 Hz, 1 H, H-4a), 2.10, 2.02 (2 × s, 6 H, 2 × Ac), 1.96 (ddd, 1 H, H-4b), 1.41 (s, 9 H, t-Bu). Compound epi -13. [α]D = -34.9 (c 0.7, CHCl3). 1H NMR (400 MHz, CDCl3):
δ = 6.85-6.78 (m, 4 H, MeOPh), 5.52 (dd, J 6,7 = 7.8 Hz, J 7,8 = 7.6 Hz, 1 H, H-7), 5.12 (dd, J 5,6 = 7.6 Hz, 1 H, H-6), 5.04 (br s, 1 H, NH), 4.69 (dd, J 8,9a = 4.6 Hz, J 9a,9b = 10.2 Hz, 1 H, H-9a), 4.28 (ddd, J 8,9b = 1.6 Hz, 1 H, H-8), 4.05-3.97 (m, 2 H, H-3, H-5), 3.94 (dd, 1 H, H-9b), 3.75 (s, 3 H, Me), 2.48 (ddd, J 3,4a = 7.6 Hz, J 4a,4b = 13.6, J 4a,5 = 9.5 Hz, 1 H, H-4a), 2.34 (ddd, J 3,4b = 2.2 Hz, J 4b,5 = 6.8 Hz, 1 H, H-4b), 2.10, 1.99 (2 × s, 6 H, 2 Ac), 1.42 (s, 9 H, t-Bu). Compound 14 Methyl Ester. [α]D =
-63.4 (c 0.3, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 5.61 (dd, J 6,7 = 9.3 Hz, J 7,8 = 8.2 Hz, 1 H, H-7), 5.10 (dd, J 5,6 = 8.4 Hz, 1 H, H-6), 5.08 (br d, J 3,NH = 7.0 Hz, 1 H, NH), 4.58 (d, 1 H, H-8), 4.53 (ddd, J 3,4a = 6.5 Hz, J 3,4b = 12.0 Hz, 1 H, H-3), 3.78 (s, 3 H, Me), 3.69 (ddd, J 4a,5 = 5.4 Hz, J 4b,5 = 9.5 Hz, 1 H, H-5), 3.02 (ddd, J 4a,4b = 12.5 Hz, 1 H, H-4a), 2.16 (ddd, 1 H, H-4b), 2.09, 2.06 (2 × s, 6 H, 2 × Ac), 1.43 (s, 9 H, t-Bu). 13C NMR (100 MHz, CDCl3): δ = 173.4 (Me3COCO), 173.3 (C-2), 170.4, 169.6 (CH3 CO), 167.8 (CO2Me), 80.1 (Me3 C), 75.7 (C-7), 75.3 (C-6), 57.7 (C-5), 56.5 (C-8), 54.3 (C-3), 52.8 (MeO), 38.8 (C-4), 28.3 (Me 3C), 20.6 and 20.3 (CH 3CO).